![Aspirin trialled as part of potential treatment for type of aggressive breast cancer | UK News | Sky News Aspirin trialled as part of potential treatment for type of aggressive breast cancer | UK News | Sky News](https://e3.365dm.com/21/08/768x432/skynews-aspirin-tablet-drug_5482285.jpg?20210818015713)
Aspirin trialled as part of potential treatment for type of aggressive breast cancer | UK News | Sky News
![Aspirin use in residual breast cancer disease improves distant metastases free survival - Hospital Healthcare Europe Aspirin use in residual breast cancer disease improves distant metastases free survival - Hospital Healthcare Europe](https://hospitalhealthcare.com/wp-content/uploads/2022/10/Aspirin-use-in-residual-breast-cancer-disease-improves-distant-metastases-free-survival-.jpg)
Aspirin use in residual breast cancer disease improves distant metastases free survival - Hospital Healthcare Europe
![Taking aspirin three times a week 'could SLASH risk of most common form of breast cancer' | Express.co.uk Taking aspirin three times a week 'could SLASH risk of most common form of breast cancer' | Express.co.uk](https://cdn.images.express.co.uk/img/dynamic/11/590x/Aspirin-breast-cancer-risk-health-tablets-sex-hormones-799196.jpg?r=1686998680160)
Taking aspirin three times a week 'could SLASH risk of most common form of breast cancer' | Express.co.uk
![Aspirin Reverses Chemotherapy Resistance in Breast Cancer Cells and Mice | American Association for the Advancement of Science (AAAS) Aspirin Reverses Chemotherapy Resistance in Breast Cancer Cells and Mice | American Association for the Advancement of Science (AAAS)](https://www.aaas.org/sites/default/files/2020-10/news_102120_aspirinCSM_fullsize.jpg)
Aspirin Reverses Chemotherapy Resistance in Breast Cancer Cells and Mice | American Association for the Advancement of Science (AAAS)
![The improved targeting of an aspirin prodrug albumin-based nanosystem for visualizing and inhibiting lung metastasis of breast cancer - Biomaterials Science (RSC Publishing) DOI:10.1039/D0BM01035A The improved targeting of an aspirin prodrug albumin-based nanosystem for visualizing and inhibiting lung metastasis of breast cancer - Biomaterials Science (RSC Publishing) DOI:10.1039/D0BM01035A](https://pubs.rsc.org/image/article/2020/BM/d0bm01035a/d0bm01035a-s1_hi-res.gif)
The improved targeting of an aspirin prodrug albumin-based nanosystem for visualizing and inhibiting lung metastasis of breast cancer - Biomaterials Science (RSC Publishing) DOI:10.1039/D0BM01035A
![IJMS | Free Full-Text | Aspirin Modifies Inflammatory Mediators and Metabolomic Profiles and Contributes to the Suppression of Obesity-Associated Breast Cancer Cell Growth IJMS | Free Full-Text | Aspirin Modifies Inflammatory Mediators and Metabolomic Profiles and Contributes to the Suppression of Obesity-Associated Breast Cancer Cell Growth](https://pub.mdpi-res.com/ijms/ijms-21-04652/article_deploy/html/images/ijms-21-04652-ag.png?1594953544)
IJMS | Free Full-Text | Aspirin Modifies Inflammatory Mediators and Metabolomic Profiles and Contributes to the Suppression of Obesity-Associated Breast Cancer Cell Growth
![Regular use of aspirin and other non-steroidal anti-inflammatory drugs and breast cancer risk for women at familial or genetic risk: a cohort study | Breast Cancer Research | Full Text Regular use of aspirin and other non-steroidal anti-inflammatory drugs and breast cancer risk for women at familial or genetic risk: a cohort study | Breast Cancer Research | Full Text](https://media.springernature.com/full/springer-static/image/art%3A10.1186%2Fs13058-019-1135-y/MediaObjects/13058_2019_1135_Fig4_HTML.png)
Regular use of aspirin and other non-steroidal anti-inflammatory drugs and breast cancer risk for women at familial or genetic risk: a cohort study | Breast Cancer Research | Full Text
![No association between low-dose aspirin use and breast cancer outcomes overall: a Swedish population-based study | Breast Cancer Research | Full Text No association between low-dose aspirin use and breast cancer outcomes overall: a Swedish population-based study | Breast Cancer Research | Full Text](https://media.springernature.com/full/springer-static/image/art%3A10.1186%2Fs13058-018-1065-0/MediaObjects/13058_2018_1065_Fig1_HTML.png)
No association between low-dose aspirin use and breast cancer outcomes overall: a Swedish population-based study | Breast Cancer Research | Full Text
![The proposed schema of the mechanisms by which aspirin breaks the crosstalk between breast cancer cells and adipocytes. The proposed schema of the mechanisms by which aspirin breaks the crosstalk between breast cancer cells and adipocytes.](https://s3-eu-west-1.amazonaws.com/ppreviews-plos-725668748/2631107/preview.jpg)